Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study.

ABSTRACT:

Background

Reporting of adverse drug events (ADEs) to regulatory authorities remains low, particularly among consumers.

Objectives

To explore stakeholders' views on the development and use of a digital platform to improve ADE reporting by consumers to the regulatory authority in Australia, i.e., the Therapeutic Goods Administration.

Methods

A qualitative study was conducted using semi-structured interviews, focus group discussions (FGDs), and co-design workshops with consumers, healthcare professionals (HCPs), and regulators. The interview recordings were transcribed verbatim, coded, and analysed thematically according to the Capability, Opportunity, Motivation, Behaviour model. Findings of the FGDs and co-design workshops were incorporated to enhance and complement t

SUBMITTER: Gebreyohannes EA 

PROVIDER: S-EPMC11785647 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature